Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Beginning Balances at Dec. 31, 2020 $ 11 $ 30,886 $ (11,688) $ 19,209
Beginning Balances (in shares) at Dec. 31, 2020 563,789      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock options   19   19
Exercise of stock options (in shares) 150      
Share issuance, net $ 1 5,061   5,062
Share issuance, net (in shares) 57,530      
Stock-based compensation   1,913   1,913
Tax impact of equity transactions   (862)   (862)
Net loss     (2,756) (2,756)
Share issuance, acquisition related $ 1 2,814   2,815
Share issuance, acquisition related (in shares) 21,606      
Convertible debt converted into common shares   60   60
Convertible debt converted into common shares (in shares) 669      
Equity component of debenture issuance   1,203   1,203
Settlement of performance share liability   2,293   2,293
Settlement of performance share liability (in shares) 2,198      
Other (in shares) 1      
Ending Balance at Dec. 31, 2021 $ 13 43,387 (14,444) 28,956
Ending Balance (in shares) at Dec. 31, 2021 645,943      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock options   4   4
Exercise of stock options (in shares) 40      
Share issuance, net $ 6 5,189   5,195
Share issuance, net (in shares) 278,804      
Stock-based compensation $ 2 1,418   1,420
Stock-based compensation (in shares) 126,311      
Tax impact of equity transactions   2   2
Net loss     (30,112) (30,112)
Ending Balance at Dec. 31, 2022 $ 21 $ 50,000 $ (44,556) $ 5,465
Ending Balance (in shares) at Dec. 31, 2022 1,051,098